12,500,000 Shares BioScrip, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • April 22nd, 2013 • BioScrip, Inc. • Retail-drug stores and proprietary stores • New York
Introductory. BioScrip, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 9,375,000 shares of its common stock, par value $0.0001 per share (the “Shares”); and the stockholders of the Company named in Schedule B (collectively, the “Selling Stockholders”) severally propose to sell to the Underwriters an aggregate of 3,125,000 Shares. The 9,375,000 Shares to be sold by the Company and the 3,125,000 Shares to be sold by the Selling Stockholders are collectively called the “Firm Shares.” In addition, the Company and the Selling Stockholders have severally granted to the Underwriters an option to purchase up to an additional 1,875,000 Shares as provided in Section 2. The additional 1,875,000 Shares to be sold by the Company and the Selling Stockholders pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exerci
